M3mP6, the promising drug for heart attacks

heart attack

The peptide-derived nanoparticle drug – M3mP6 high-loading peptide nanoparticle (HLPN) – was tested in mice as a possible treatment for heart attacks.

Photo credit: Shutterstock

A new drug that prevents blood clots without bringing about increased risk of bleeding, which is a common side-effect of all anti-platelet medications currently available, is delivering incredible results according to researchers.


You're all set to enjoy unlimited Prime content.